Published in Am J Transplant on January 01, 2007
Daclizumab versus antithymocyte globulin in high-immunological-risk renal transplant recipients. J Am Soc Nephrol (2009) 2.08
Donor age and renal P-glycoprotein expression associate with chronic histological damage in renal allografts. J Am Soc Nephrol (2009) 1.69
Listing for expanded criteria donor kidneys in older adults and those with predicted benefit. Am J Transplant (2010) 1.65
New insights into postrenal transplant hemolytic uremic syndrome. Nat Rev Nephrol (2010) 1.36
Framing disparities along the continuum of care from chronic kidney disease to transplantation: barriers and interventions. Am J Transplant (2009) 1.22
Association of lower costs of pulsatile machine perfusion in renal transplantation from expanded criteria donors. Am J Transplant (2008) 0.96
Aggressive immunosuppression minimization reduces graft loss following diagnosis of BK virus-associated nephropathy: a comparison of two reduction strategies. Clin J Am Soc Nephrol (2008) 0.93
Renal transplantation with early steroid withdrawal. Pediatr Nephrol (2008) 0.88
Current trends and short-term outcomes of live donor nephrectomy: a population-based analysis of the nationwide inpatient sample. World J Surg (2010) 0.84
Perceived discrimination predicts longer time to be accepted for kidney transplant. Transplantation (2012) 0.84
The CLEAR study: a 5-day, 3-g loading dose of mycophenolate mofetil versus standard 2-g dosing in renal transplantation. Clin J Am Soc Nephrol (2010) 0.84
Accept or refuse? Factors influencing the decision-making of transplant surgeons who are offered a pancreas: results of a qualitative study. BMC Surg (2013) 0.82
Gender and living donor kidney transplantation. Wien Med Wochenschr (2011) 0.82
Antibody-mediated rejection of the kidney after simultaneous pancreas-kidney transplantation. J Am Soc Nephrol (2008) 0.80
Pancreas transplantation: lessons learned from a decade of experience at Wake Forest Baptist Medical Center. Rev Diabet Stud (2011) 0.79
Tacrolimus increases Nox4 expression in human renal fibroblasts and induces fibrosis-related genes by aberrant TGF-beta receptor signalling. PLoS One (2014) 0.77
Membranes to achieve immunoprotection of transplanted islets. Front Biosci (Landmark Ed) (2014) 0.77
Pancreas transplantation: differences in activity between Europe and the United States. Nephrol Dial Transplant (2009) 0.75
Extended pancreas donor program - the EXPAND study rationale and study protocol. Transplant Res (2013) 0.75
Sacral neuromodulation enabling simultaneous pancreas and kidney transplantation: a first case. BMJ Case Rep (2009) 0.75
Donor Characteristics of Pancreas Transplantation in Australia and New Zealand: A Cohort Study 1984-2014. Transplant Direct (2016) 0.75
Protocol of the KTFT-TALK study to reduce racial disparities in kidney transplant evaluation and living donor kidney transplantation. Contemp Clin Trials (2016) 0.75
Predictors of non-transplantation of adult donor organs--an observational study using routine data from Eurotransplant. BMC Health Serv Res (2014) 0.75
A pilot study of gene expression-based categorization of pancreas transplant biopsies. Transplantation (2009) 0.75
Short-term outcome and quality of life in kidney transplant recipient with monoclonal gammopathy. CEN Case Rep (2016) 0.75
First Canadian experience with donation after cardiac death simultaneous pancreas and kidney transplants. Can J Surg (2017) 0.75
Effectiveness and safety of calcineurin inhibitor withdrawal in kidney transplantation: a meta-analysis of randomized controlled trials. Clin Exp Nephrol (2015) 0.75
Klotho enhances FoxO3-mediated manganese superoxide dismutase expression by negatively regulating PI3K/AKT pathway during tacrolimus-induced oxidative stress. Cell Death Dis (2017) 0.75
Liver transplantation in the United States, 1999-2008. Am J Transplant (2010) 3.92
Survival benefit-based deceased-donor liver allocation. Am J Transplant (2009) 2.89
HIV-infected liver and kidney transplant recipients: 1- and 3-year outcomes. Am J Transplant (2007) 2.50
Liver and intestine transplantation in the United States, 1997-2006. Am J Transplant (2008) 2.04
Proceedings of Consensus Conference on Simultaneous Liver Kidney Transplantation (SLK). Am J Transplant (2008) 1.81
Recovery and utilization of deceased donor kidneys from small pediatric donors. Am J Transplant (2006) 1.68
Organ donation and utilization, 1995-2004: entering the collaborative era. Am J Transplant (2006) 1.57
DonorNet and the potential effects on organ utilization. Am J Transplant (2010) 1.53
Simultaneous liver-kidney transplantation summit: current state and future directions. Am J Transplant (2012) 1.50
Utilization of kidneys with similar kidney donor risk index values from standard versus expanded criteria donors. Am J Transplant (2012) 1.46
Organ donation and utilization in the United States: 1998-2007. Am J Transplant (2009) 1.45
Extent and severity of coronary disease and mortality in patients with end-stage renal failure evaluated for renal transplantation. Am J Transplant (2009) 1.45
The effects of donor and recipient practices on transplant center finances. Am J Transplant (2008) 1.44
Simultaneous liver-kidney transplantation: evaluation to decision making. Am J Transplant (2007) 1.22
Solving the organ shortage crisis: the 7th annual American Society of Transplant Surgeons' State-of-the-Art Winter Symposium. Am J Transplant (2008) 1.21
Kidney and pancreas transplantation in the United States, 1998-2007: access for patients with diabetes and end-stage renal disease. Am J Transplant (2009) 1.18
Impact of MELD-based allocation on end-stage renal disease after liver transplantation. Am J Transplant (2011) 1.17
Kidney and pancreas transplantation in the United States, 1995-2004. Am J Transplant (2006) 1.14
Risk factors for urinary complications after renal transplantation. Am J Transplant (2007) 1.10
Clinical utility of monitoring tacrolimus blood concentrations in liver transplant patients. J Clin Pharmacol (2001) 1.07
Delayed function reduces renal allograft survival independent of acute rejection. Nephrol Dial Transplant (1996) 1.05
Who pays for biliary complications following liver transplant? A business case for quality improvement. Am J Transplant (2006) 1.03
Sex-based disparities in liver transplant rates in the United States. Am J Transplant (2011) 1.02
Pediatric transplantation in the United States, 1995-2004. Am J Transplant (2006) 1.01
Conversion of exocrine secretions from bladder to enteric drainage in recipients of whole pancreaticoduodenal transplants. Ann Surg (1992) 0.99
Cyclic AMP phosphodiesterases of human and rat islets of Langerhans: contributions of types III and IV to the modulation of insulin secretion. Biochem Biophys Res Commun (1995) 0.97
Treatment of invasive cytomegalovirus disease in solid organ transplant patients with ganciclovir. Transplantation (1991) 0.97
Should pediatric patients wait for HLA-DR-matched renal transplants? Am J Transplant (2008) 0.97
Innovations in the assessment of transplant center performance: implications for quality improvement. Am J Transplant (2009) 0.95
Transplant center quality assessment using a continuously updatable, risk-adjusted technique (CUSUM). Am J Transplant (2006) 0.94
Systematic evaluation of pancreas allograft quality, outcomes and geographic variation in utilization. Am J Transplant (2010) 0.93
Pharmacokinetics and concentration-control investigations of mycophenolic acid in adults after transplantation. Ther Drug Monit (2000) 0.93
The effect of renal insufficiency on mycophenolic acid protein binding. J Clin Pharmacol (1999) 0.91
Pharmacokinetic, pharmacodynamic, and outcome investigations as the basis for mycophenolic acid therapeutic drug monitoring in renal and heart transplant patients. Clin Biochem (2001) 0.90
Assembly of G protein-coupled receptors from fragments: identification of functional receptors with discontinuities in each of the loops connecting transmembrane segments. Biochemistry (1999) 0.90
Financial implications of pancreas transplant complications: a business case for quality improvement. Am J Transplant (2007) 0.90
Adenoviral transfection of isolated pancreatic islets: a study of programmed cell death (apoptosis) and islet function. J Surg Res (1997) 0.88
Pharmacokinetics of mycophenolic acid in renal transplant patients with delayed graft function. J Clin Pharmacol (1998) 0.87
Short sirolimus half-life in pediatric renal transplant recipients on a calcineurin inhibitor-free protocol. Pediatr Transplant (2004) 0.85
Development of anti-human leukocyte antigen class 1 antibodies following allogeneic islet cell transplantation. Transplant Proc (2005) 0.85
Prevention of diabetes in BB rats by intermittent administration of cyclosporine. Surgery (1987) 0.84
Prevention of recurrent autoimmune diabetes in BB rats by anti-asialo-GM1 antibody. Diabetes (1988) 0.83
Transthoracic, transdiaphragmatic excision of simultaneous lung and adrenal lesions. Ann Thorac Surg (1998) 0.83
Primary nonfunction of islet xenografts in rat recipients results from non-T-cell-mediated immune responses. Transplant Proc (1997) 0.82
Reversal of acute renal allograft rejection by extracorporeal photopheresis: a case presentation and review of the literature. J Clin Apher (1996) 0.80
Analysis, pharmacokinetics and therapeutic drug monitoring of mycophenolic acid. Clin Biochem (1998) 0.80
NK cells, macrophages, and humoral immune responses are dominant in primary nonfunction of islet grafts in the dog-to-rat xenotransplant model. Transplant Proc (1997) 0.79
The effect of clinical and biochemical donor parameters on pancreatic islet isolation yield from cadaveric organ donors. Ann Transplant (1996) 0.79
Case 3-1995. Three patients requiring both coronary artery bypass surgery and orthotopic liver transplantation. J Cardiothorac Vasc Anesth (1995) 0.79
Preliminary analysis of early outcomes of a prospective, randomized trial of complete steroid avoidance in liver transplantation. Transplant Proc (2005) 0.79
Interaction between tacrolimus and chloramphenicol in a renal transplant recipient. Transplantation (1998) 0.79
Time-trends in publication productivity of young transplant surgeons in the United States. Am J Transplant (2011) 0.78
Vancomycin-resistant enterococci: an emerging pathogen in immunosuppressed transplant recipients. Transplant Proc (1995) 0.78
Race and delayed kidney allograft function. Nephrol Dial Transplant (1998) 0.78
Scientific principles for mycophenolic acid therapeutic drug monitoring. Transplant Proc (1998) 0.78
Decreased rejection episodes in African-American renal transplant recipients receiving mycophenolate mofetil/tacrolimus therapy. Transplant Proc (1997) 0.78
FTY720-loaded poly(DL-lactide-co-glycolide) electrospun scaffold significantly increases microvessel density over 7 days in streptozotocin-induced diabetic C57b16/J mice: preliminary results. Transplant Proc (2011) 0.78
Analysis of donor age and cold ischemia time as factors in cadaveric human islet isolation. Transplant Proc (1994) 0.78
Long-term culture or complement inhibition improves early islet function in dog to rat islet xenotransplantation. Transplant Proc (1996) 0.78
IL-10 and TGF-beta gene transfer to rodent islets: effect on xenogeneic islet graft survival in naive and B-cell-deficient mice. Transplant Proc (1997) 0.78
Assessment of differences in HLA-A, -B, and -DRB1 allele mismatches among African-American and non-African-American recipients of deceased kidney transplants. Transplant Proc (2007) 0.78
Young transplant surgeons and NIH funding. Am J Transplant (2010) 0.77
Transfer of genes for IL-10 and TGF-beta to isolated human pancreatic islets. Transplant Proc (1997) 0.77
Advances in therapeutic drug monitoring for immunosuppressants: a review of sirolimus. Introduction and overview. Clin Ther (2000) 0.77
Prospective investigations of concentration-clinical response for immunosuppressive drugs provide the scientific basis for therapeutic drug monitoring. Clin Chem (1998) 0.76
Uncontrolled DCDs: the next step? Am J Transplant (2006) 0.76
Cyclosporin A inhibits nitric oxide production in an in vitro xenogeneic islet/splenocyte co-culture system. Transplant Proc (1994) 0.76
IL-10 and TGF-beta gene transfer for xenogeneic islet transplantation: comparison of effect in concordant vs discordant combination. Transplant Proc (1997) 0.76
Long-term metabolic function of pancreas transplants and influence of rejection episodes. Transplantation (1991) 0.76
FK-506 therapeutic drug monitoring. Clin Chem (1994) 0.75
Neonatal tolerance induction in diabetes-prone BB rats as a model for donor-specific pancreas transplantation during adulthood. Transplant Proc (1992) 0.75
Renal transplantation at the University of Michigan 1964 to 1999. Clin Transpl (1999) 0.75
Two new DNA synthesis inhibitors with potent immunosuppressive activity prolong allograft and xenograft survival in small and large animals. Transplant Proc (1996) 0.75
Local production of CTLA4-Ig by adenoviral-mediated gene transfer to the pancreas induces permanent allograft survival and donor-specific tolerance. Transplant Proc (1999) 0.75
Transplantation. JAMA (1995) 0.75
Major-histocompatibility-complex restricted and nonrestricted autoimmune effector mechanisms in BB rats. Transplantation (1991) 0.75
Islet xenografts in mice and rats: I. Exocrine tissue is detrimental to engraftment and survival of human islet xenografts. Transplant Proc (1994) 0.75
Noninvasive evaluation of bladder-drained whole pancreaticoduodenal transplants with magnetic resonance angiography. Transplant Proc (1994) 0.75
Microlymphocytotoxicity assay to assess reactivity of rodent sera to large animal T lymphocytes. Transplant Proc (1994) 0.75
Influence of pretransplant cytomegalovirus serology and treatment of rejection upon disease after kidney and kidney plus pancreas transplantation. Transplant Proc (1992) 0.75
Islet xenografts in mice and rats: II. Mixed islet-spleen cell assay to analyze nitric oxide production and inhibition in xenogeneic species combinations. Transplant Proc (1994) 0.75
Percutaneous transluminal angioplasty: the procedure of choice for renal allograft artery stenosis. Transplant Proc (1987) 0.75
Gene therapy strategies to facilitate organ transplantation. Mol Med Today (1999) 0.75
Prevention of autoimmune damage to islet grafts in BB rats by antibody therapy. Transplant Proc (1989) 0.75
Reduced NO production improves early canine islet xenograft function: a role for nitric oxide in islet xenograft primary nonfunction. Cell Transplant (2001) 0.75
Victor Satinsky (1912-1997) and the success of his partially occluding vascular clamp. Trans Stud Coll Physicians Phila (2000) 0.75
Simultaneous kidney-pancreas transplantation. Minerva Urol Nefrol (2007) 0.75
Organ transplantation in the twenty-first century. Urol Clin North Am (1998) 0.75
Efficacy and safety of dithizone in staining of islet cell transplants. Transplant Proc (1995) 0.75
Factors that can affect cadaveric islet graft function include hemodynamic changes in the donor prior to organ harvest. Transplant Proc (1996) 0.75
Engraftment and function of intrathymic pancreatic islet autografts in dogs. Transplant Proc (1995) 0.75
Nonimmunogenic perinatal islets, transplanted intrathymically to BB/Wor recipients, do not prevent onset of autoimmune diabetes. Transplant Proc (1994) 0.75
Converting exocrine drainage from bladder to bowel in recipients of whole pancreaticoduodenal transplants. Transplant Proc (1992) 0.75
Annual literature review--clinical transplants 2000. Clin Transpl (2000) 0.75
Fludarabine phosphate and 2-chlorodeoxyadenosine: immunosuppressive DNA synthesis inhibitors with potential application in islet allo- and xenotransplantation. Transplant Proc (1995) 0.75
Increased DNA fragmentation in isolated rat islets following 24 hour co-culture with cytokine transgene-bearing adenovirus is dose dependent, but does not reduce glucose-stimulated insulin secretion. Transplant Proc (1997) 0.75
Comparison of MHC-incompatible intraportal islet and vascularized whole-pancreas transplantation in the prehyperglycemic phase of autoimmune diabetes. Transplant Proc (1994) 0.75
Occurrence and prevention of graft-vs-host disease after pancreaticoduodenal transplantation in the BB rat. Transplant Proc (1993) 0.75
Streptozotocin-induced hyperglycemia in rats: analysis of complement activity after streptozotocin administration. Transplant Proc (1995) 0.75
In vitro assessment of human islets for transplantation: a comparison of glucose-stimulated insulin secretion from short-term-cultured (< 48 hours) versus long-term-cultured (> 72 hours) human islets. Transplant Proc (1994) 0.75